
Ultrasonics Sonochemistry 102 (2024) 106732
2
challenges. A commonly utilized wall material in this context is
β-cyclodextrin (β-CD), owing to its external hydrophilic and internal
hydrophobic characteristics. The hydrophobic groups of the products
can stably bind with the interior of β-CD, resulting in a favorable
embedding effect [6–9]. It has been reported that thymol can form an
inclusion complex with β-cyclodextrin to enhance its water solubility
and thermodynamic stability based on the preservation of its own bio-
logical activity [6]. In addition, ultrasonic technology has been shown to
be effective in creating encapsulated materials with specic physical and
functional properties, due to its cavitation and mechanical effects
[10–13]. This is attributed to the wide range of active frequencies of
ultrasound, enabling precise control over the intensity and frequency of
cavitation events, which in turn can be utilized to manipulate material
properties such as particle size, surface roughness, and structure [11].
Consequently, this technique has the potential to enhance the functional
properties of materials. Sun et al. [13] reported that ultrasound can
improve the solubility and thermal stability of the inclusion complex of
thymol with 2-hydroxypropyl-β-cyclodextrin by improving the complex
structure and increasing the molecular interactions, such as hydrogen
bonding and hydrophobic interactions. Hence, a promising strategy to
produce peptide-chelated calcium microcapsules exhibiting enhanced
solubility, thermal stability, and controlled release is suggested by
combining encapsulation and ultrasonic technology. Currently, the most
common ultrasonic encapsulation is single-frequency ultrasonic device.
There is extensive evidence that synchronous dual-frequency sonication
signicantly increases mechanical disturbance and cavitation yield
compared to a single-frequency ultrasound, due to the stronger intensity
of the ultrasonic eld generated by the superposition of the two fre-
quencies, the lower cavitation threshold and the enhanced nucleation
and collapse of bubbles [14,15]. Chen et al. [16] found that dual-
frequency ultrasound generated a greater number of cavitation bub-
bles and exhibited a stronger cavitation effect on Qingke protein
compared to single-frequency ultrasound. However, there is currently a
lack of research and scientic reports exploring the application of ul-
trasonic technology, specically advanced dual-frequency ultrasound,
in the production of peptide-chelated calcium microcapsules. Therefore,
the core aim of this study was to employ the synchronous dual-frequency
ultrasonic enhancement technique to fabricate corn peptide-chelated
calcium microcapsules encapsulated with β-CD. The innovative aspect
of our study is focused on determining the encapsulation rate and yield,
as well as exploring the effects of encapsulation and ultrasound tech-
niques on the structure, solubility, thermal stability, and slow-release
properties of the microcapsules. These ndings aim to evaluate the po-
tential of the microcapsules as a promising alternative for high calcium
supplementation.
2. Materials and methods
2.1. Materials
Corn gluten meal was obtained from Jiahui Feed Enterprise (Hebei,
China). Neutrase and Alcalase (the activity of 50 U/mg and 269 U/mg,
respectively) were purchased from Novozymes Co., ltd. (Jiangsu,
China). Pepsin and trypsin (the activity of 3000 U/mg and 250 U/mg,
respectively) were purchased from Sigma Company (St. Louis, MO,
USA). β-CD, ethylenedinitrilotetraacetic acid (EDTA) and other analyt-
ical grade chemicals were purchased from Sinopharm Chemical Reagent
Co. Ltd (Shanghai, China).
Corn peptide was prepared following the procedure outlined in our
previous publication [4]. Corn gluten meal solution (80 mg/mL) was
hydrolyzed using Neutrase at an enzyme-substrate ratio of 2000 U/g, pH
7, 50 ◦C for 2.5 h. The resulting solution was then subjected to ultra-
ltration purication (using a 30 kDa membrane), to obtain the corn
permeates (10.86 mg/mL, 1.5 L). These permeates were subsequently
hydrolyzed further using Alcalase at an enzyme-substrate ratio of 8000
U/g, pH 8.5, and 40 ◦C for 5 h. The hydrolysis process was performed
using synchronous dual-frequency ultrasound (20/28 kHz) at a power of
225 W, a duty ratio of 10/5 s/s, and four cycles (with a work-time of 40
min and a stop-time of 20 min). After another round of ultraltration
purication (using a 3 kDa membrane) and dialysis (with a size cutoff of
100 Da), the resulting solution was obtained as the corn peptide
solution.
2.2. Preparing corn peptide chelated calcium microcapsules using
ultrasonication method
Corn peptide-chelated calcium was prepared according to our pre-
vious publication [4]. The CaCl
2
was added to the corn peptide solution
(36 mg/mL, 15 mL) at a mass ratio of 1:8 g/g, pH 7, 40 ◦C for a chelating
time of 40 min. The reaction solution was then mixed with eight times
the volume of absolute ethanol to precipitate the chelate for 60 min at
25 ◦C. The chelate precipitates were removed from ethanol-soluble non-
chelated calcium and peptides by centrifugation at 4000×g for 15 min,
collected, and then freeze-dried. The freeze-dried chelate was
completely dissolved in distilled water and mixed with the β-CD aqueous
solution using the synchronous dual-frequency (20/28 kHz) ultrasound
for a total embedding time of 30 min to ensure complete embedding. The
microcapsule supernatant was collected after centrifugation (4000×g
for 15 min), and then freeze-dried. The effects of chelate concentration
(1, 2.5, 5, 7.5, 10 mg/mL), mass ratio of chelate to β-CD (1:2, 1:4, 1:6,
1:8, 1:10 g/g), ultrasonic power (6, 25, 50, 75, 100 W), duty ratio (10/5,
20/5, 30/5, 50/5 s/s), and time (5, 10, 15, 20, 30 min) on the encap-
sulation rate of chelate and the yield of microcapsules were studied to
investigate the effects of various parameters on the preparation of
microcapsules.
2.3. Encapsulation rate and yield measurements
The encapsulation rate was determined according to the method of
Chen et al. [17] with some modications. Freeze-dried microcapsules
(50 mg) were dissolved uniformly in absolute ethanol (25 mL). The
ethanol-insoluble precipitates (i.e. unmicroencapsulated chelates) were
removed from the ethanol-soluble microcapsules by centrifugation at
4000×g for 15 min, collected and then freeze-dried. The dried unmi-
croencapsulated chelate was completely dissolved in distilled water and
the calcium content was measured by the EDTA titration method ac-
cording to our previous publication [4]. The encapsulation rate and the
yield were calculated using Equations (1) and (2):
Encapsulation rate(%) = (1−m
′
2
m
′
1
) × 100 (1)
Yield (%) = m0
m
′
3+m
′
4
×100 (2)
where, m
1
′
is the initial calcium content in the sample (mg), m
2
′
is the
calcium content in the unmicroencapsulated chelate (mg), m
0
is the dry
mass of microcapsules (mg), m
3
′
is the dry mass of chelate (mg), and m
4
′
is the dry mass of β-CD (mg).
2.4. Fourier transform infrared (FTIR) spectroscopy
The chelate, β-CD, and microcapsules were mixed with dry potas-
sium bromide in a mass ratio of 1:100, uniformly ground, and pressed
into 1–2 mm akes. The ake was loaded on the FTIR spectrograph
(Thermo Fisher Scientic Corporation, USA). The spectra of the samples
were recorded with a scan range of 4000–500 cm
−1
by 32 scans at a
resolution of 4 cm
−1
.
W. Qu et al.